Paltusotine was granted Orphan Drug Designation for the treatment of acromegaly by the FDA in July 2020. This designation is ...

Patients with acromegaly make too much growth hormone, which causes them to grow disproportionately large bones, organs and ...

The FDA has accepted the NDA for paltusotine for the treatment and long-term maintenance of acromegaly in adults.

Paltusotine was granted orphan drug designation for the treatment of acromegaly by the FDA in July 2020. Orphan drug ...

Pharmaceuticals announced the U.S. Food and Drug Administration, FDA, accepted its New Drug Application, NDA, for ...

JMP Securities analyst Jonathan Wolleben has reiterated their bullish stance on CRNX stock, giving a Buy rating today.Pick the best stocks and ...

Sandostatin (octreotide acetate) is a prescription drug used to treat acromegaly and other conditions. Sandostatin can cause side effects that range from mild to serious. Examples include diarrhea ...

New World screwworm was largely eradicated from the U.S. and Central America in the 1960s and 1980s, respectively. But the ...

Medication for AFib focuses on controlling heart rate, controlling heart rhythm, or preventing blood clots. Share on Pinterest Marc Tran/Stocksy United Atrial fibrillation (AFib) is the most ...

Submission of New Drug Application for Paltusotine for the Treatment of Acromegaly Completed Upsized Public Offering of $575M ...

Somatostatin analogues are clinically used for the treatment of acromegaly and have the benefit ... retinoic acid in Cushing's syndrome. This medication is teratogenic and is not currently ...